Clinical parameters
Parameter . | Group 1 . | Group 2 . | Group 3 . |
---|---|---|---|
Blood transfusions | 2.3 ± 0.6 | 2 ± 0.5 | 1.7 ± 0.3 |
WBCs | |||
Days <500 | 2.3 ± 1.3 | 2 ± 0.5 | 2.6 ± 0.3 |
Nadir, n/μL | 286 ± 101 | 196 ± 23 | 256 ± 58 |
Days of nadir | 8 ± 0.5 | 7 ± 0 | 9 ± 2 |
Days to >500 | 13 ± 1.5 | 12 ± 1.3 | 14.6 ± 1.7 |
Days to >1 000 | 17 ± 1.2 | 17 ± 1 | 19 ± 1 |
ANC | |||
Days <500 | 3.6 ± 1.2 | 3 ± 0.5 | 4 ± 0 |
Nadir, n/μL | 70 ± 50 | 63 ± 14.5 | 43 ± 23 |
Days of nadir | 7 ± 1.1 | 6 ± 1 | 8 ± 1.3 |
Days to >500 | 15 ± 1.7 | 15 ± 2.3 | 18 ± 0 |
Days to >1 000 | 19.6 ± 0.6 | 19.6 ± 1.2 | 19 ± 1 |
Platelets | |||
Nadir, n/μL | 9 000 ± 7 549 | 7 000 ± 6 027 | 12 666 ± 5 487 |
Days of nadir | 18 ± 5.5 | 20 ± 2.9 | 15 ± 2.8 |
Days to >20 000 | 20 ± 6 | 29.5 ± 4.5 | 18 ± 3.7 |
Parameter . | Group 1 . | Group 2 . | Group 3 . |
---|---|---|---|
Blood transfusions | 2.3 ± 0.6 | 2 ± 0.5 | 1.7 ± 0.3 |
WBCs | |||
Days <500 | 2.3 ± 1.3 | 2 ± 0.5 | 2.6 ± 0.3 |
Nadir, n/μL | 286 ± 101 | 196 ± 23 | 256 ± 58 |
Days of nadir | 8 ± 0.5 | 7 ± 0 | 9 ± 2 |
Days to >500 | 13 ± 1.5 | 12 ± 1.3 | 14.6 ± 1.7 |
Days to >1 000 | 17 ± 1.2 | 17 ± 1 | 19 ± 1 |
ANC | |||
Days <500 | 3.6 ± 1.2 | 3 ± 0.5 | 4 ± 0 |
Nadir, n/μL | 70 ± 50 | 63 ± 14.5 | 43 ± 23 |
Days of nadir | 7 ± 1.1 | 6 ± 1 | 8 ± 1.3 |
Days to >500 | 15 ± 1.7 | 15 ± 2.3 | 18 ± 0 |
Days to >1 000 | 19.6 ± 0.6 | 19.6 ± 1.2 | 19 ± 1 |
Platelets | |||
Nadir, n/μL | 9 000 ± 7 549 | 7 000 ± 6 027 | 12 666 ± 5 487 |
Days of nadir | 18 ± 5.5 | 20 ± 2.9 | 15 ± 2.8 |
Days to >20 000 | 20 ± 6 | 29.5 ± 4.5 | 18 ± 3.7 |
Data are presented as mean ± standard error.
ANC, absolute neutrophil count; WBC, white blood cell.